V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220017826 | 220018068 | 1.81 | 73.8 | Curative (C) | 2017-01-31 | 2017-02-18 | METHOTREXATE | N | N | 220033448 | CISPLATIN + GEMCITABINE |
| 220017827 | 220008880 | 1.67 | 80.6 | Palliative (P) | 2018-04-02 | 2018-04-07 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 220033449 | PACLITAXEL |
| 220017828 | 220014759 | 1.62 | null | null | null | 2018-09-01 | Paclitaxel 7 day | N | N | 220033449 | PACLITAXEL |
| 220017829 | 220008884 | null | 81.2 | Curative (C) | 2018-01-14 | 2018-01-15 | PONATINIB | 2 | N | 220033473 | OXALIPLATIN + MDG |
| 220017830 | 220019915 | null | 86.75 | Curative (C) | 2016-11-22 | 2017-08-20 | Mitoxantrone | N | N | 220033474 | MITOXANTRONE |
| 220017831 | 220008889 | 1.72 | 58.4 | Disease modification (D) | 2016-06-22 | 2016-06-24 | PONATINIB | N | N | 220033475 | OXALIPLATIN + MDG |
| 220017832 | 220008892 | 1.81 | 58.3 | Adjuvant (A) | 2014-02-06 | 2014-02-20 | Alemtuzumab cond (RI ALLO CAMP100) | 2 | N | 220033480 | ALEMTUZUMAB |
| 220017833 | 220014762 | null | 78 | Curative (C) | 2017-01-05 | 2017-01-05 | CARBOPLATIN + PACLITAXEL | null | null | 220033484 | CARBOPLATIN + PACLITAXEL |
| 220017834 | 220014763 | 1.63 | 65.1 | Curative (C) | 2016-06-21 | 2017-02-24 | Carboplatin + Etoposide IV 3 day | 02 | N | 220033493 | CARBOPLATIN + ETOPOSIDE |
| 220017835 | 220008897 | 1.65 | 81.8 | Curative (C) | 2015-09-28 | 2015-11-16 | PONATINIB | 2 | N | 220033508 | GEMCARBO |
| 220017836 | 220008901 | null | null | Curative (C) | 2015-07-18 | 2015-07-18 | Mitoxantrone | 2 | null | 220033511 | MITOXANTRONE |
| 220017837 | 220008905 | 1.78 | null | Disease modification (D) | 2014-03-11 | 2014-03-27 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220033515 | CARBOPLATIN + PACLITAXEL |
| 220017838 | 220018073 | 1.65 | 47 | Adjuvant (A) | null | 2016-11-17 | Fludarabine + Melphalan RIC Allo | null | null | 220033519 | FBC |
| 220017839 | 220021913 | null | 72 | Not known (9) | 2016-05-03 | 2016-05-03 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | 02 | null | 220033520 | IRINOTECAN + MDG |
| 220017840 | 220008908 | 1.79 | 77.8 | Adjuvant (A) | 2014-01-11 | 2014-02-02 | FLUOROURACIL + IRINOTECAN | N | N | 220033525 | FLUDARABINE + MELPHALAN |
| 220017841 | 220008909 | 1.83 | 59.3 | Curative (C) | 2014-06-16 | 2014-06-18 | Cytarabine intrathecal | 99 | N | 220033542 | CYTARABINE INTRATHECAL |
| 220017842 | 220008909 | null | 64.8 | Curative (C) | 2015-04-03 | 2015-05-03 | GEMTUZUMAB OZOGAMICIN | N | N | 220033542 | PONATINIB |
| 220017843 | 220008910 | 1.74 | 71.4 | Curative (C) | 2016-05-26 | 2016-05-26 | Paclitaxel (2 or 3 weekly) | 2 | N | 220033551 | PACLITAXEL |
| 220017844 | 220019920 | null | 92 | Curative (C) | 2018-05-26 | 2018-07-17 | ECX | N | N | 220033567 | ECX |
| 220017845 | 220008915 | 1.56 | 58 | Palliative (P) | 2015-10-14 | 2015-10-14 | CARBOPLATIN + PACLITAXEL | N | null | 220033571 | CARBOPLATIN + PACLITAXEL |
| 220017846 | 220008918 | 1.76 | 105 | Curative (C) | 2016-07-22 | 2016-07-23 | Irinotecan + Modified De Gramont | null | null | 220033572 | FBC |
| 220017847 | 220008922 | 1.72 | 85.699 | Curative (C) | 2014-03-17 | 2014-03-17 | UKALL14- FMC (1 day) Conditioning | Y | null | 220033590 | OXALIPLATIN + MDG |
| 220017848 | 220008924 | 1.76 | 87.7 | Curative (C) | null | 2014-04-15 | PONATINIB | Y | null | 220033598 | FBC |
| 220017849 | 220008925 | null | 79 | Curative (C) | 2013-04-10 | 2013-09-20 | Cytarabine intrathecal | N | N | 220033607 | CYTARABINE INTRATHECAL |
| 220017850 | 220008927 | 1.66 | 58.6 | Curative (C) | 2017-01-06 | 2017-01-06 | GEMTUZUMAB OZOGAMICIN | 02 | N | 220033611 | UKALL2014 |
| 220017851 | 220008929 | 1.79 | 80 | Curative (C) | 2015-04-02 | 2015-04-02 | Clofarabine + Cytarabine | 2 | N | 220033623 | UKALL2014 |
| 220017852 | 220008931 | 1.79 | 94.2 | Curative (C) | null | 2016-02-05 | IDARUBICIN | N | N | 220033631 | IDARUBICIN |
| 220017853 | 220014777 | 1.66 | 61 | Curative (C) | 2016-06-18 | 2016-06-29 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220033670 | ALEMTUZUMAB |
| 220017854 | 220014777 | 1.59 | 59.3 | Disease modification (D) | 2017-04-06 | 2017-06-01 | Arsenic trioxide + Tretinoin | Y | null | 220033670 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017855 | 220014778 | 1.83 | 87 | Adjuvant (A) | 2016-12-24 | 2017-01-14 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220033680 | UKALL2014 |
| 220017856 | 220014779 | null | 67.6 | Palliative (P) | 2015-03-29 | 2015-03-29 | Arsenic trioxide + Tretinoin | 02 | N | 220033681 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017857 | 220008937 | 1.73 | 84.2 | null | 2017-11-26 | 2018-01-07 | Docetaxel 75mg/m2 (21 day) | 2 | N | 220033692 | CLOFARABINE + CYTARABINE |
| 220017858 | 220014781 | 1.68 | 76 | Curative (C) | null | 2015-11-20 | ECX | N | N | 220033699 | DOCETAXEL |
| 220017859 | 220014781 | null | 89.7 | Palliative (P) | 2016-02-04 | 2016-03-05 | Oxaliplatin + Modified de Gramont | N | N | 220033699 | PONATINIB |
| 220017860 | 220008942 | 1.73 | 80.6 | null | 2018-07-13 | 2018-07-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 220033709 | CARBOPLATIN + PACLITAXEL |
| 220017861 | 220014782 | 1.55 | 44.5 | Palliative (P) | 2014-05-31 | 2014-05-31 | Mitox + Tretinoin Spanish Course 3 | 02 | N | 220033709 | MITOXANTRONE |
| 220017862 | 220008944 | 1.55 | null | Palliative (P) | 2016-06-01 | 2016-09-25 | Carboplatin + Paclitaxel (3 weekly) | N | N | 220033720 | CARBOPLATIN + PACLITAXEL |
| 220017863 | 220014785 | 1.64 | 84 | Adjuvant (A) | 2017-10-04 | 2017-11-29 | Docetaxel | 2 | N | 220033722 | ECX |
| 220017865 | 220008948 | null | 58.2 | Palliative (P) | 2015-04-14 | 2015-04-14 | CARBOPLATIN + PACLITAXEL | N | N | 220033737 | CARBOPLATIN + PACLITAXEL |
| 220017867 | 220008958 | 1.5 | 52.8 | Curative (C) | 2017-01-22 | 2017-01-29 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 220033807 | IRINOTECAN + MDG |
| 220017868 | 220008966 | 1.67 | 81.7 | Palliative (P) | 2018-03-06 | 2018-03-24 | Arsenic trioxide + Tretinoin | 02 | Y | 220033808 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017869 | 220008971 | 1.7 | 78.7 | Palliative (P) | 2015-11-08 | 2015-11-10 | Fludarabine + Melphalan RIC Allo | 2 | N | 220033810 | CISPLATIN + GEMCITABINE |
| 220017870 | 220008972 | 1.74 | 53.5 | Curative (C) | 2013-08-06 | 2013-10-08 | Arsenic Triox + Tretinoin Ind W5-8 | 2 | N | 220033816 | ARSENIC TRIOXIDE + TRETINOIN |
| 220017871 | 220008974 | 1.67 | 71.6 | Curative (C) | 2017-03-24 | 2017-04-03 | GEMTUZUMAB OZOGAMICIN | 2 | N | 220033829 | ECX |
| 220017872 | 220014799 | 1.6 | 75.45 | Curative (C) | 2016-01-27 | 2016-01-27 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220033832 | DOCETAXEL |
| 220017873 | 220008977 | 1.52 | 85 | Curative (C) | 2017-05-17 | 2017-05-19 | Alemtuzumab cond (RI ALLO CAMP100) | N | N | 220033846 | ALEMTUZUMAB |
| 220017874 | 220008978 | 1.76 | 113.1 | Adjuvant (A) | null | 2018-10-27 | FLUOROURACIL + IRINOTECAN | 2 | Y | 220033850 | DOCETAXEL |
| 220017875 | 220008979 | null | 48.1 | Palliative (P) | 2015-06-25 | 2015-06-28 | FLUOROURACIL + IRINOTECAN | 02 | null | 220033854 | IRINOTECAN + MDG |
| 220017876 | 220008981 | 1.78 | 90.8 | Disease modification (D) | 2017-08-20 | 2017-09-07 | Carboplatin + Etoposide IV 3 day | N | N | 220033857 | CARBOPLATIN + ETOPOSIDE |
| 220017877 | 220014802 | 1.78 | null | Curative (C) | 2015-10-12 | 2016-03-26 | CARBOPLATIN + PACLITAXEL | N | N | 220033858 | CARBOPLATIN + PACLITAXEL |